4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004369
Options or other derivatives
- Chief Executive Officer acquired 6,488,496 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2023-01-17 | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 | D: show line 1 in the form | ||
| Rawcliffe Adrian Chief Executive Officer | 2023-01-17 | Grant or award · Option to purchase Ordinary Shares | +1,798,272 | 1,798,272 | D: show line 2 in the form |
Loading xslF345X03/tm231655-9_4seq1.xml…